Frontiers in Virology · 2022 · 13 citations · 6 references
Life SciencesInfectious DiseasesMicrobiologyGenomicsMedical MicrobiologyVirologyDna SequencingGenomic SurveillanceMolecular SurveillanceNext-generation SequencingVariant DetectionViral GenomicsSars-cov-2 InfectionSars-cov-2 Variant SurveillanceVariant Emergence StudiesVariant Of Concern DetectionViral Variant DetectionViral Variant Monitoring
Molecular surveillance of SARS-CoV-2 is crucial for the early detection of new variants and lineages. In addition, detection of co-infections with more than one SARS-CoV-2 lineage has been sporadically reported. In this work, surveillance of SARS-CoV-2 variants was performed on 2,067 RNA samples (Ct > 30) obtained during December 2021 and January 2022 from Córdoba province, Argentina, by real-time RT-PCR specific for variants of concern (VOCs) and variants of interest (VOIs) relevant mutations (TaqMan™ SARS-CoV-2 Mutation Panel, Applied Biosystems). The following distribution of variants was obtained: Omicron (54.9%), Delta (44.2%), and Lambda (0.8%). Three samples (0.1%), from the last week of December, were compatible with a Delta/Omicron co-infection. One of them was sequenced by NGS-Illumina, obtaining reads for both VOCs. One of the co-infected patients presented with severe symptoms, was not vaccinated, and had risk factors (older than 60 years and arterial hypertension). We describe for the first time in Argentina the identification of cases of co-infection with two SARS-CoV-2 lineages, VOCs Delta and Omicron, during the third COVID-19 wave in the country (a high viral circulation period), when Delta and Omicron co-circulated. Our findings highlight the importance of continuing molecular surveillance, in order to elucidate possible recombination events and the emergence of new variants.
6
Using Tablet for visual exploration of second-generation sequencing data
Iain Milne, Gordon Stephen, Micha Bayer et al. · Briefings in Bioinformatics · 2012 · 1K citations · Full text
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Xuemei He, Weiqi Hong, Xiangyu Pan et al. · MedComm · 2021 · 538 citations · Full text
Life Sciences, Infectious Disease Control, Infectious Diseases +14
Salome Hosch, Maxmillian Mpina, Elizabeth Nyakurungu et al. · Frontiers in Public Health · 2022 · 27 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +16